Genesis Therapeutics and Genentech Collab for New AI-Driven Discovery Drug Mission: $52 Million Budget Raised! Genesis Therapeutics wants to put a theoretical molecule into a simulation. The tech giant now collaborates with Genentech! by Giuliano J. de Leon
Healthy Living/Wellness FDA Approves Genentech Drug Alecensa For ALK-Positive Lung Cancer by Katherine Derla
Healthy Living/Wellness Experimental Drug Ocrelizumab Proves Successful Against Hard-To-Treat Type Of Multiple Sclerosis by Ted Ranosa
Healthy Living/Wellness 23andMe to Sell DNA Data of Parkinson's Customers to Genentech for $60 Million by Rhodi Lee
Healthy Living/Wellness Genentech Submits New Drug Application for Cobimetinib with Zelboraf for Treating Advanced Melanoma by Dianne Depra
Healthy Living/Wellness Skin cancer drug by Roche meets goals during late-stage testing by Dianne Depra